Logo1 logo2
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
  Q-Line Biotech Ltd
Registered Office: 298-281 Transport Nagar Kanpur,#NAME? , Lucknow - 226012 , Uttar Pradesh , India.
Phone : +91 522 2435 570   Fax:
Email :  compliance@qlinebiotech.com  
Website :  www.qlinebiotech.com
Initial public offer of upto 62,53,200 equity shares of face value of rupee10/- each (the "Equity Shares") of Q-Line Biotech Limited ("the Company" or "QLBL" or "the Issuer") at an issue price of rupee343 per equity share (including share premium of rupee333 per equity share) for cash, aggregating up to rupee214.48 Crores ("Public Issue") out of which 3,13,200 equity shares of face value of rupee10/- each, at an issue price of rupee343 per equity share for cash, aggregating rupee10.74 Crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. Issue of 59,40,000 equity shares of face value of rupee10/- each, at an issue price of rupee343 per equity share for cash, aggregating upto rupee203.74 Crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.81% and 25.46% respectively of the post- issue paid-up equity share capital of the company. The company, in consultation with the book running lead managers, may consider a pre-ipo placement of up to 8,00,000 equity shares for cash consideration ("pre-ipo placement") prior to filing of the pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the book running lead managers. If the pre-ipo placement is undertaken, the number of equity shares issued pursuant to the pre-ipo placement shall be reduced from the issue, subject to compliance with Rule 19(2)(b) of the securities contracts (Regulation) rules, 1957, as amended ("scrr"). Price Band: rupee343 per equity share of face value rupee10/- each. The floor price (rupee343) is 34.3 times of the face value of the equity shares. Bids can be made for a minimum of 800 equity shares and in multiples of 400 equity shares thereafter.

Issue Money Payable On
Opens On Closes On Application Allotment
21-May-26 25-May-26 Rs343.00-0.00 Rs0.00-0.00
Minimum Application for shares in Nos :800  Further Multiples of :400

  RsCr Lead Managers to the Issue
Project Cost 188.60
Hem Securities Limited
Project Financed through Current Offer 214.48  
Post Issue Equity Share Capital 23.33  
Issue Price Rs343.00  
 
Projects
 To meet Working Capital requirements General corporate purposes
 Repayment of certain borrowing availed by the Company, in part or full
Promoted By
 Saurabh Garg
 Amita Garg
 Ayush Garg
Listing At
 NSE - SME 
Registrar to the Issue
 Purva Sharegistry (I) Pvt Ltd